Correlation Between Scpharmaceuticals and Bio Path
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Bio Path at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Bio Path into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Bio Path Holdings, you can compare the effects of market volatilities on Scpharmaceuticals and Bio Path and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Bio Path. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Bio Path.
Diversification Opportunities for Scpharmaceuticals and Bio Path
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Scpharmaceuticals and Bio is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Bio Path Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Path Holdings and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Bio Path. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Path Holdings has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Bio Path go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and Bio Path
Given the investment horizon of 90 days Scpharmaceuticals is expected to under-perform the Bio Path. But the stock apears to be less risky and, when comparing its historical volatility, Scpharmaceuticals is 1.88 times less risky than Bio Path. The stock trades about -0.09 of its potential returns per unit of risk. The Bio Path Holdings is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 91.00 in Bio Path Holdings on August 30, 2024 and sell it today you would lose (14.00) from holding Bio Path Holdings or give up 15.38% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scpharmaceuticals vs. Bio Path Holdings
Performance |
| Timeline |
| Scpharmaceuticals |
| Bio Path Holdings |
Scpharmaceuticals and Bio Path Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and Bio Path
The main advantage of trading using opposite Scpharmaceuticals and Bio Path positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Bio Path can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Path will offset losses from the drop in Bio Path's long position.| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
| Bio Path vs. Capricor Therapeutics | Bio Path vs. NextCure | Bio Path vs. Pulmatrix | Bio Path vs. Crinetics Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |